Your browser doesn't support javascript.
loading
Management of patients with brain metastases from NSCLC without a genetic driver alteration: upfront radiotherapy or immunotherapy?
Merkin, Ross D; Chiang, Veronica L; Goldberg, Sarah B.
Affiliation
  • Merkin RD; Department of Medicine, Section of Medical Oncology, Yale University School of Medicine, Yale Cancer Center, 333 Cedar Street, PO Box 208028, New Haven, CT 06520, USA.
  • Chiang VL; Department of Medicine, Section of Medical Oncology, Yale University School of Medicine, Yale Cancer Center, New Haven, CT, USA.
  • Goldberg SB; Department of Neurosurgery, Yale University School of Medicine, Yale Cancer Center, New Haven, CT, USA.
Ther Adv Med Oncol ; 15: 17588359231175438, 2023.
Article in En | MEDLINE | ID: mdl-37275964
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Ther Adv Med Oncol Year: 2023 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Ther Adv Med Oncol Year: 2023 Document type: Article Affiliation country: United States Country of publication: United kingdom